The global market for Radioimmunotherapy was valued at US$ 2383 million in the year 2024 and is projected to reach a revised size of US$ 6119 million by 2031, growing at a CAGR of 14.6% during the forecast period.

Radioimmunotherapy Market

Radioimmunotherapy (RIT) is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of radiation. The treatment involves attaching radioactive isotopes to monoclonal antibodies, which are specialized proteins that can recognize and bind to specific antigens found on the surface of cancer cells.

Global key Companies of Radioimmunotherapy include Novartis, Bayer, etc. The top two players hold a share over 98%. North America is the largest market, with a share about 62%, followed by Europe and Asia-Pacific, with the share about 29% and 8%. In terms of product type, Beta-emitting occupy the largest share of the total market, about 90%.

This report aims to provide a comprehensive presentation of the global market for Radioimmunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioimmunotherapy.

The Radioimmunotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radioimmunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Radioimmunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Radioimmunotherapy Market Report

Report Metric	Details
Report Name	Radioimmunotherapy Market
Accounted market size in year	US$ 2383 million
Forecasted market size in 2031	US$ 6119 million
CAGR	14.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Beta-emitting Targeted Alpha Therapy
Segment by Application	Solid Tumor Non Hodgkin Lymphoma
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Curium Pharmaceuticals, Gilead Sciences, Clarity Pharmaceuticals, Curasight, Nordic Nanovector, Philogen, RadioMedix, Telix Pharmaceuticals, Orano Med, Actinium Pharmaceuticals, Y-mAbs Therapeutics, Fusion Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radioimmunotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Radioimmunotherapy Market growing?

Ans: The Radioimmunotherapy Market witnessing a CAGR of 14.6% during the forecast period 2025-2031.

What is the Radioimmunotherapy Market size in 2031?

Ans: The Radioimmunotherapy Market size in 2031 will be US$ 6119 million.

What is the market share of major companies in Radioimmunotherapy Market?

Ans: The top two players hold a share over 98%.

What is the Radioimmunotherapy Market share by region?

Ans: North America is the largest market, with a share about 62%, followed by Europe and Asia-Pacific, with the share about 29% and 8%.

What is the Radioimmunotherapy Market share by type?

Ans: In terms of product type, Beta-emitting occupy the largest share of the total market, about 90%.

Who are the main players in the Radioimmunotherapy Market report?

Ans: The main players in the Radioimmunotherapy Market are Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Curium Pharmaceuticals, Gilead Sciences, Clarity Pharmaceuticals, Curasight, Nordic Nanovector, Philogen, RadioMedix, Telix Pharmaceuticals, Orano Med, Actinium Pharmaceuticals, Y-mAbs Therapeutics, Fusion Pharmaceuticals

What are the Application segmentation covered in the Radioimmunotherapy Market report?

Ans: The Applications covered in the Radioimmunotherapy Market report are Solid Tumor, Non Hodgkin Lymphoma

What are the Type segmentation covered in the Radioimmunotherapy Market report?

Ans: The Types covered in the Radioimmunotherapy Market report are Beta-emitting, Targeted Alpha Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Radioimmunotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Beta-emitting

1.2.3 Targeted Alpha Therapy

1.3 Market by Application

1.3.1 Global Radioimmunotherapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Solid Tumor

1.3.3 Non Hodgkin Lymphoma

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Radioimmunotherapy Market Perspective (2020-2031)

2.2 Global Radioimmunotherapy Growth Trends by Region

2.2.1 Global Radioimmunotherapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Radioimmunotherapy Historic Market Size by Region (2020-2025)

2.2.3 Radioimmunotherapy Forecasted Market Size by Region (2026-2031)

2.3 Radioimmunotherapy Market Dynamics

2.3.1 Radioimmunotherapy Industry Trends

2.3.2 Radioimmunotherapy Market Drivers

2.3.3 Radioimmunotherapy Market Challenges

2.3.4 Radioimmunotherapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Radioimmunotherapy Players by Revenue

3.1.1 Global Top Radioimmunotherapy Players by Revenue (2020-2025)

3.1.2 Global Radioimmunotherapy Revenue Market Share by Players (2020-2025)

3.2 Global Radioimmunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Radioimmunotherapy Revenue

3.4 Global Radioimmunotherapy Market Concentration Ratio

3.4.1 Global Radioimmunotherapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Radioimmunotherapy Revenue in 2024

3.5 Global Key Players of Radioimmunotherapy Head office and Area Served

3.6 Global Key Players of Radioimmunotherapy, Product and Application

3.7 Global Key Players of Radioimmunotherapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Radioimmunotherapy Breakdown Data by Type

4.1 Global Radioimmunotherapy Historic Market Size by Type (2020-2025)

4.2 Global Radioimmunotherapy Forecasted Market Size by Type (2026-2031)

5 Radioimmunotherapy Breakdown Data by Application

5.1 Global Radioimmunotherapy Historic Market Size by Application (2020-2025)

5.2 Global Radioimmunotherapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Radioimmunotherapy Market Size (2020-2031)

6.2 North America Radioimmunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Radioimmunotherapy Market Size by Country (2020-2025)

6.4 North America Radioimmunotherapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Radioimmunotherapy Market Size (2020-2031)

7.2 Europe Radioimmunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Radioimmunotherapy Market Size by Country (2020-2025)

7.4 Europe Radioimmunotherapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Radioimmunotherapy Market Size (2020-2031)

8.2 Asia-Pacific Radioimmunotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Radioimmunotherapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Radioimmunotherapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Radioimmunotherapy Market Size (2020-2031)

9.2 Latin America Radioimmunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Radioimmunotherapy Market Size by Country (2020-2025)

9.4 Latin America Radioimmunotherapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Radioimmunotherapy Market Size (2020-2031)

10.2 Middle East & Africa Radioimmunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Radioimmunotherapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Radioimmunotherapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer Radioimmunotherapy Introduction

11.1.4 Bayer Revenue in Radioimmunotherapy Business (2020-2025)

11.1.5 Bayer Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Radioimmunotherapy Introduction

11.2.4 Novartis Revenue in Radioimmunotherapy Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Lantheus

11.3.1 Lantheus Company Details

11.3.2 Lantheus Business Overview

11.3.3 Lantheus Radioimmunotherapy Introduction

11.3.4 Lantheus Revenue in Radioimmunotherapy Business (2020-2025)

11.3.5 Lantheus Recent Development

11.4 Aurobindo Pharma

11.4.1 Aurobindo Pharma Company Details

11.4.2 Aurobindo Pharma Business Overview

11.4.3 Aurobindo Pharma Radioimmunotherapy Introduction

11.4.4 Aurobindo Pharma Revenue in Radioimmunotherapy Business (2020-2025)

11.4.5 Aurobindo Pharma Recent Development

11.5 Mundipharma

11.5.1 Mundipharma Company Details

11.5.2 Mundipharma Business Overview

11.5.3 Mundipharma Radioimmunotherapy Introduction

11.5.4 Mundipharma Revenue in Radioimmunotherapy Business (2020-2025)

11.5.5 Mundipharma Recent Development

11.6 China Isotope & Radiation

11.6.1 China Isotope & Radiation Company Details

11.6.2 China Isotope & Radiation Business Overview

11.6.3 China Isotope & Radiation Radioimmunotherapy Introduction

11.6.4 China Isotope & Radiation Revenue in Radioimmunotherapy Business (2020-2025)

11.6.5 China Isotope & Radiation Recent Development

11.7 Curium Pharmaceuticals

11.7.1 Curium Pharmaceuticals Company Details

11.7.2 Curium Pharmaceuticals Business Overview

11.7.3 Curium Pharmaceuticals Radioimmunotherapy Introduction

11.7.4 Curium Pharmaceuticals Revenue in Radioimmunotherapy Business (2020-2025)

11.7.5 Curium Pharmaceuticals Recent Development

11.8 Gilead Sciences

11.8.1 Gilead Sciences Company Details

11.8.2 Gilead Sciences Business Overview

11.8.3 Gilead Sciences Radioimmunotherapy Introduction

11.8.4 Gilead Sciences Revenue in Radioimmunotherapy Business (2020-2025)

11.8.5 Gilead Sciences Recent Development

11.9 Clarity Pharmaceuticals

11.9.1 Clarity Pharmaceuticals Company Details

11.9.2 Clarity Pharmaceuticals Business Overview

11.9.3 Clarity Pharmaceuticals Radioimmunotherapy Introduction

11.9.4 Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2020-2025)

11.9.5 Clarity Pharmaceuticals Recent Development

11.10 Curasight

11.10.1 Curasight Company Details

11.10.2 Curasight Business Overview

11.10.3 Curasight Radioimmunotherapy Introduction

11.10.4 Curasight Revenue in Radioimmunotherapy Business (2020-2025)

11.10.5 Curasight Recent Development

11.11 Nordic Nanovector

11.11.1 Nordic Nanovector Company Details

11.11.2 Nordic Nanovector Business Overview

11.11.3 Nordic Nanovector Radioimmunotherapy Introduction

11.11.4 Nordic Nanovector Revenue in Radioimmunotherapy Business (2020-2025)

11.11.5 Nordic Nanovector Recent Development

11.12 Philogen

11.12.1 Philogen Company Details

11.12.2 Philogen Business Overview

11.12.3 Philogen Radioimmunotherapy Introduction

11.12.4 Philogen Revenue in Radioimmunotherapy Business (2020-2025)

11.12.5 Philogen Recent Development

11.13 RadioMedix

11.13.1 RadioMedix Company Details

11.13.2 RadioMedix Business Overview

11.13.3 RadioMedix Radioimmunotherapy Introduction

11.13.4 RadioMedix Revenue in Radioimmunotherapy Business (2020-2025)

11.13.5 RadioMedix Recent Development

11.14 Telix Pharmaceuticals

11.14.1 Telix Pharmaceuticals Company Details

11.14.2 Telix Pharmaceuticals Business Overview

11.14.3 Telix Pharmaceuticals Radioimmunotherapy Introduction

11.14.4 Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2020-2025)

11.14.5 Telix Pharmaceuticals Recent Development

11.15 Orano Med

11.15.1 Orano Med Company Details

11.15.2 Orano Med Business Overview

11.15.3 Orano Med Radioimmunotherapy Introduction

11.15.4 Orano Med Revenue in Radioimmunotherapy Business (2020-2025)

11.15.5 Orano Med Recent Development

11.16 Actinium Pharmaceuticals

11.16.1 Actinium Pharmaceuticals Company Details

11.16.2 Actinium Pharmaceuticals Business Overview

11.16.3 Actinium Pharmaceuticals Radioimmunotherapy Introduction

11.16.4 Actinium Pharmaceuticals Revenue in Radioimmunotherapy Business (2020-2025)

11.16.5 Actinium Pharmaceuticals Recent Development

11.17 Y-mAbs Therapeutics

11.17.1 Y-mAbs Therapeutics Company Details

11.17.2 Y-mAbs Therapeutics Business Overview

11.17.3 Y-mAbs Therapeutics Radioimmunotherapy Introduction

11.17.4 Y-mAbs Therapeutics Revenue in Radioimmunotherapy Business (2020-2025)

11.17.5 Y-mAbs Therapeutics Recent Development

11.18 Fusion Pharmaceuticals

11.18.1 Fusion Pharmaceuticals Company Details

11.18.2 Fusion Pharmaceuticals Business Overview

11.18.3 Fusion Pharmaceuticals Radioimmunotherapy Introduction

11.18.4 Fusion Pharmaceuticals Revenue in Radioimmunotherapy Business (2020-2025)

11.18.5 Fusion Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Clarity Pharmaceuticals

Telix Pharmaceuticals

China Isotope & Radiation

Curium Pharmaceuticals

Gilead Sciences

Orano Med

Actinium Pharmaceuticals

Y-mAbs Therapeutics

Fusion Pharmaceuticals

List of Tables

Table 1. Global Radioimmunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Beta-emitting

Table 3. Key Players of Targeted Alpha Therapy

Table 4. Global Radioimmunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Radioimmunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Radioimmunotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Radioimmunotherapy Market Share by Region (2020-2025)

Table 8. Global Radioimmunotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Radioimmunotherapy Market Share by Region (2026-2031)

Table 10. Radioimmunotherapy Market Trends

Table 11. Radioimmunotherapy Market Drivers

Table 12. Radioimmunotherapy Market Challenges

Table 13. Radioimmunotherapy Market Restraints

Table 14. Global Radioimmunotherapy Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Radioimmunotherapy Market Share by Players (2020-2025)

Table 16. Global Top Radioimmunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioimmunotherapy as of 2024)

Table 17. Ranking of Global Top Radioimmunotherapy Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Radioimmunotherapy Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Radioimmunotherapy, Headquarters and Area Served

Table 20. Global Key Players of Radioimmunotherapy, Product and Application

Table 21. Global Key Players of Radioimmunotherapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Radioimmunotherapy Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Radioimmunotherapy Revenue Market Share by Type (2020-2025)

Table 25. Global Radioimmunotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Radioimmunotherapy Revenue Market Share by Type (2026-2031)

Table 27. Global Radioimmunotherapy Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Radioimmunotherapy Revenue Market Share by Application (2020-2025)

Table 29. Global Radioimmunotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Radioimmunotherapy Revenue Market Share by Application (2026-2031)

Table 31. North America Radioimmunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Radioimmunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Radioimmunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Radioimmunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Radioimmunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Radioimmunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Radioimmunotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Radioimmunotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Radioimmunotherapy Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Radioimmunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Radioimmunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Radioimmunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Radioimmunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Radioimmunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Radioimmunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Bayer Company Details

Table 47. Bayer Business Overview

Table 48. Bayer Radioimmunotherapy Product

Table 49. Bayer Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 50. Bayer Recent Development

Table 51. Novartis Company Details

Table 52. Novartis Business Overview

Table 53. Novartis Radioimmunotherapy Product

Table 54. Novartis Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 55. Novartis Recent Development

Table 56. Lantheus Company Details

Table 57. Lantheus Business Overview

Table 58. Lantheus Radioimmunotherapy Product

Table 59. Lantheus Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 60. Lantheus Recent Development

Table 61. Aurobindo Pharma Company Details

Table 62. Aurobindo Pharma Business Overview

Table 63. Aurobindo Pharma Radioimmunotherapy Product

Table 64. Aurobindo Pharma Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 65. Aurobindo Pharma Recent Development

Table 66. Mundipharma Company Details

Table 67. Mundipharma Business Overview

Table 68. Mundipharma Radioimmunotherapy Product

Table 69. Mundipharma Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 70. Mundipharma Recent Development

Table 71. China Isotope & Radiation Company Details

Table 72. China Isotope & Radiation Business Overview

Table 73. China Isotope & Radiation Radioimmunotherapy Product

Table 74. China Isotope & Radiation Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 75. China Isotope & Radiation Recent Development

Table 76. Curium Pharmaceuticals Company Details

Table 77. Curium Pharmaceuticals Business Overview

Table 78. Curium Pharmaceuticals Radioimmunotherapy Product

Table 79. Curium Pharmaceuticals Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 80. Curium Pharmaceuticals Recent Development

Table 81. Gilead Sciences Company Details

Table 82. Gilead Sciences Business Overview

Table 83. Gilead Sciences Radioimmunotherapy Product

Table 84. Gilead Sciences Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 85. Gilead Sciences Recent Development

Table 86. Clarity Pharmaceuticals Company Details

Table 87. Clarity Pharmaceuticals Business Overview

Table 88. Clarity Pharmaceuticals Radioimmunotherapy Product

Table 89. Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 90. Clarity Pharmaceuticals Recent Development

Table 91. Curasight Company Details

Table 92. Curasight Business Overview

Table 93. Curasight Radioimmunotherapy Product

Table 94. Curasight Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 95. Curasight Recent Development

Table 96. Nordic Nanovector Company Details

Table 97. Nordic Nanovector Business Overview

Table 98. Nordic Nanovector Radioimmunotherapy Product

Table 99. Nordic Nanovector Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 100. Nordic Nanovector Recent Development

Table 101. Philogen Company Details

Table 102. Philogen Business Overview

Table 103. Philogen Radioimmunotherapy Product

Table 104. Philogen Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 105. Philogen Recent Development

Table 106. RadioMedix Company Details

Table 107. RadioMedix Business Overview

Table 108. RadioMedix Radioimmunotherapy Product

Table 109. RadioMedix Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 110. RadioMedix Recent Development

Table 111. Telix Pharmaceuticals Company Details

Table 112. Telix Pharmaceuticals Business Overview

Table 113. Telix Pharmaceuticals Radioimmunotherapy Product

Table 114. Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 115. Telix Pharmaceuticals Recent Development

Table 116. Orano Med Company Details

Table 117. Orano Med Business Overview

Table 118. Orano Med Radioimmunotherapy Product

Table 119. Orano Med Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 120. Orano Med Recent Development

Table 121. Actinium Pharmaceuticals Company Details

Table 122. Actinium Pharmaceuticals Business Overview

Table 123. Actinium Pharmaceuticals Radioimmunotherapy Product

Table 124. Actinium Pharmaceuticals Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 125. Actinium Pharmaceuticals Recent Development

Table 126. Y-mAbs Therapeutics Company Details

Table 127. Y-mAbs Therapeutics Business Overview

Table 128. Y-mAbs Therapeutics Radioimmunotherapy Product

Table 129. Y-mAbs Therapeutics Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 130. Y-mAbs Therapeutics Recent Development

Table 131. Fusion Pharmaceuticals Company Details

Table 132. Fusion Pharmaceuticals Business Overview

Table 133. Fusion Pharmaceuticals Radioimmunotherapy Product

Table 134. Fusion Pharmaceuticals Revenue in Radioimmunotherapy Business (2020-2025) & (US$ Million)

Table 135. Fusion Pharmaceuticals Recent Development

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

Table 139. Authors List of This Report

List of Figures

Figure 1. Radioimmunotherapy Picture

Figure 2. Global Radioimmunotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Radioimmunotherapy Market Share by Type: 2024 VS 2031

Figure 4. Beta-emitting Features

Figure 5. Targeted Alpha Therapy Features

Figure 6. Global Radioimmunotherapy Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Radioimmunotherapy Market Share by Application: 2024 VS 2031

Figure 8. Solid Tumor Case Studies

Figure 9. Non Hodgkin Lymphoma Case Studies

Figure 10. Radioimmunotherapy Report Years Considered

Figure 11. Global Radioimmunotherapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Radioimmunotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Radioimmunotherapy Market Share by Region: 2024 VS 2031

Figure 14. Global Radioimmunotherapy Market Share by Players in 2024

Figure 15. Global Top Radioimmunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioimmunotherapy as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Radioimmunotherapy Revenue in 2024

Figure 17. North America Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Radioimmunotherapy Market Share by Country (2020-2031)

Figure 19. United States Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Radioimmunotherapy Market Share by Country (2020-2031)

Figure 23. Germany Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Radioimmunotherapy Market Share by Region (2020-2031)

Figure 31. China Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Radioimmunotherapy Market Share by Country (2020-2031)

Figure 39. Mexico Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Radioimmunotherapy Market Share by Country (2020-2031)

Figure 43. Turkey Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Radioimmunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Bayer Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 47. Novartis Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 48. Lantheus Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 49. Aurobindo Pharma Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 50. Mundipharma Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 51. China Isotope & Radiation Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 52. Curium Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 53. Gilead Sciences Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 54. Clarity Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 55. Curasight Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 56. Nordic Nanovector Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 57. Philogen Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 58. RadioMedix Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 59. Telix Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 60. Orano Med Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 61. Actinium Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 62. Y-mAbs Therapeutics Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 63. Fusion Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global CGT CDMO Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34J6684

Fri Mar 14 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Minimal Residual Disease (MRD) Dynamic Monitor Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3A15503

Thu Mar 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Independent Clinical Laboratory (ICL) Service Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10U15290

Thu Mar 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Boron Neutron Capture Therapy (BNCT) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11S15473

Thu Mar 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions